: Lexeo Therapeutics files for IPO
Lexeo Therapeutics filed for an IPO on Friday. The company develops genetic medicines, with candidates for treatment of Friedreich’s ataxia and Alzheimer’s currently being evaluated....
: Dow falls 160 points Friday, S&P 500 posts worst monthly drop since December
Stocks closed mostly lower on Friday, with the S&P 500 cementing its biggest drop in a month since December, as a surge in bond yields...
: Intel’s stock scores its hottest quarterly winning streak since 2010
Intel Corp. INTC shares rose for a fourth consecutive quarter Friday, giving the chip maker its longest quarterly winning streak in 13-and-a-half years. Intel shares...
: Biogen gets FDA approval for biotech treatment similar to Roche’s Actemra
Biogen Inc. BIIB said late Friday the Food and Drug Administration approved its biosimilar version of Roche CH:ROG‘s arthritis treatment Actemra. Biogen said its treatment...
: Cruise operators’ stocks are sliding after Carnival warns of rising fuel costs
Cruise operators’ stocks are slumping after Carnival Corp. CCL on Friday warned of rising fuel prices that impacted the company’s earnings. Carnival’s stock plunged 8%...
: The 2 highest yielding S&P 500 sector ETFs are Q3’s worst performers
The two worst performing S&P 500 sectors during the third quarter were utilities and real estate investment trusts, as a jump in Treasury yields made...
: Oil futures end lower for the session, higher for the month and quarter
Oil futures declined on Friday, but U.S. prices notched a gain of nearly 9% for the month. “Oil was solidly on its path to $100,...
: McCarthy maintains tough tone as government shutdown on Sunday looks unavoidable
House Speaker Kevin McCarthy, a California Republican, didn’t give any indications during a news conference Friday that he would make a deal with the Democratic-run...